新政出台 行业“洗牌” New regulation for new drug approval process: is it a signal for industry reorganization?

蔡江南, 姜天一 (Participant Author)

Research output: Contribution to journalJournal

Abstract

中欧卫生管理与政策中心主任蔡江南:去年以来,关于药品的注册、审批和知识产权方面,国家频频出台重要政策。
Original languageChinese (Simplified)
Pages (from-to)66-70
Journal中国卫生
Issue number7
DOIs
Publication statusPublished - 2016

Cite this